首页 > 市场调查报告书 > 医疗设备

导管

再灌注治疗市场：依治疗类型、按损伤类型、按分销管道、按地区：规模、份额、前景、机会分析，2023-2030

市场调查报告书

商品编码

1350237

再灌注治疗市场：依治疗类型、按损伤类型、按分销管道、按地区：规模、份额、前景、机会分析，2023-2030

Reperfusion Treatment Market, By Treatment Type, By Injury Type, By Distribution Channel, and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年08月16日 | 出版商:

Coherent Market Insights | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计到 2023 年，全球再灌注治疗市场价值将达到 15.467 亿美元，预测期内（2023-2030 年）复合年增长率为 4.7%。

报告范围		报告详情
基准年	2022年	2023年市场规模	美国：15.467亿美元
之前的数据	2018年至2021年	预测期	2023-2030
预测 2023-2030 年复合年增长率：	4.70%	2030年价值预测	21.358 亿美元

再灌注疗法用于恢復心臟病发作后阻塞动脉的血流。再灌注损伤通常因器官移植或其他损伤而发生。患者接受抗血小板治疗、开放性或血管内再灌注治疗、冠状动脉成形术。再灌注伤害可发生在心臟、肾臟、肝臟、肠、肺和脑部等器官。治疗再灌注伤害药物的临床试验正在进行中。当血液供应不足导致组织损伤时，就会发生再灌注伤害。中风后的脑损伤是再灌注伤害的一个例子。再灌注治疗导致血液流入组织，因发炎和氧化压力造成氧化损伤。低温治疗、硫化氢疗法、环孢菌素和干细胞疗法用于治疗再灌注伤害。当再灌注治疗延迟时会发生氧化损伤。

市场动态

新产品的推出以及主要市场参与者不断增加的併购预计将推动全球再灌注治疗市场的成长。例如，2021 年 10 月 15 日，针对教育得主的广泛平台 Study.com 发表了一篇文章，描述了向身体组织供应含氧血液的过程（称为灌注）。为了了解灌注何时发生，医生必须先定义一些与心动週期相关的术语。一次心跳有两个週期。第一个週期称为 "润滑" 或收缩期，发生在心室收缩并将血液泵入动脉时。第二个週期，也称为“dub”或舒张期，是心室放鬆并充满血液的时候。

本研究的主要特点

本报告详细分析了全球再灌注治疗市场，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和复合年增长率（CAGR）。
它还阐明了不同细分市场的潜在收入机会，并解释了该市场有吸引力的投资主张矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和批准、市场趋势、区域前景、主要参与者采取的竞争策略等的重要见解。
它根据公司亮点、产品组合、主要亮点、财务表现和策略等参数，介绍了全球再灌注治疗市场的主要参与者。
本研究涵盖的主要公司包括 Corline Biomedical AB、SBI Holdings Inc.、Pharming Group NV、Mallinckrodt Pharmaceuticals、MIFCOR, Inc.、CFM Pharma Holding BV、Balmes Transplantation SAS、Revive Therapeutics Ltd、Faraday Pharmaceuticals、Radikal Therapeutics Inc、Akalas 、 com, Inc、Angion Biomedica Corp、Young Therapeutics, LLC、Ischemix、Stealth Biotherapeutics Inc 和Bolder Bio Technology Inc.
该报告的见解使行销人员和公司高管能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球再灌注治疗市场报告针对该行业的各个利益相关者，如投资者、供应商、产品製造商、分销商、新进入者和财务分析师。
利害关係人将透过用于分析全球再灌注治疗市场的各种策略矩阵来促进决策。

Corline Biomedical AB
SBI Holdings Inc.
Pharming Group NV
Mallinckrodt Pharmaceuticals
MIFCOR, Inc.
CFM Pharma Holding B.V
Balmes Transplantation SAS
Revive Therapeutics Ltd
Faraday Pharmaceuticals
Radikal Therapeutics Inc
Amyndas Pharmaceuticals, com, Inc.
Angion Biomedica Corp
Young Therapeutics, LLC
Ischemix
Stealth Biotherapeutics Inc
Bolder Bio Technology Inc

第10章

调查方法
关于出版商

简介目录

Product Code: CMI4248

The global reperfusion treatment market is estimated to be valued at US$ 1,546.7 Million in 2023 and is expected to exhibit a CAGR of 4.7% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 1,546.7 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	4.70%	2030 Value Projection:	US$ 2,135.8 Mn

Reperfusion therapy is used to restore blood flow in blocked arteries after a heart attack. Reperfusion injury usually occurs as a result of organ transplantation and other injuries. Patients are treated with antiplatelet therapy, open or endovascular revascularization, coronary angioplasty, and others. Reperfusion injury can occur in organs such as the heart, kidneys, liver, intestines, lungs, and brain. Clinical trials are being conducted with drugs designed to treat reflux injuries. Damage to the tissue as a result of a lack of blood supply leads to reperfusion injuries. Brain damage following a stroke is one example of a reperfusion injuries. Reperfusion therapy causes blood to flow into the tissue thatcauses inflammation and oxidative damage from oxidative stress. Therapeutic hypothermia, hydrogen sulfide therapy, cyclosporins, stem cell therapy, and other methods can all be used to treat reperfusion injury. Oxidative damage happens when reperfusion therapy is delayed.

Market Dynamics

Increasing launches of new products and mergers and acquisitions by key market players are expected to drive the global reperfusion treatment market growth. For instance, on October 15, 2021, Study.com, the extensive platform for education gainers, published an article explaining the process of delivering oxygenated blood to the body's tissues known as perfusion. Physicians must first define a few terms related to the heart beat cycle in order to comprehend when perfusion occurs. Two cycles make up one heartbeat. The first cycle, referred to as the "lub," or systole, occurs when the chambers constrict and drive blood into the arteries. The second cycle, also known as the "dub" or diastole, is when the chambers relax and blood fills them.

Key features of the study:

This report provides an in-depth analysis of the global reperfusion treatment market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global reperfusion treatment market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Corline Biomedical AB, SBI Holdings Inc., Pharming Group NV, Mallinckrodt Pharmaceuticals, MIFCOR, Inc., CFM Pharma Holding B.V, Balmes Transplantation SAS, Revive Therapeutics Ltd, Faraday Pharmaceuticals, Radikal Therapeutics Inc, Amyndas Pharmaceuticals, com, Inc, Angion Biomedica Corp, Young Therapeutics, LLC, Ischemix, Stealth Biotherapeutics Inc, and Bolder Bio Technology Inc
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global reperfusion treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global reperfusion treatment market

Detailed Segmentation:

Global Reperfusion Treatment Market, By Treatment Type:
- Therapeutic Hypothermia
- Cyclosporin
- Stem Cell Therapy
- Hydrogen Sulphide Treatment
- Others
Global Reperfusion Treatment Market, By Injury Type:
- Heart Injury
- Kidney Injury
- Intestine Injury
- Others
Global Reperfusion Treatment Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Others
Global Reperfusion Treatment Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
Company Profiles
- Corline Biomedical AB
- SBI Holdings Inc.
- Pharming Group NV
- Mallinckrodt Pharmaceuticals
- MIFCOR, Inc.
- CFM Pharma Holding B.V
- Balmes Transplantation SAS
- Revive Therapeutics Ltd
- Faraday Pharmaceuticals
- Radikal Therapeutics Inc
- Amyndas Pharmaceuticals, com, Inc.
- Angion Biomedica Corp
- Young Therapeutics, LLC
- Ischemix
- Stealth Biotherapeutics Inc
- Bolder Bio Technology Inc

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Treatment Type
- Market Snapshot, By Injury Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaboration
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Reperfusion Treatment Market- COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Reperfusion Treatment Market, By Treatment Type, 2018-2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Therapeutic Hypothermia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Cyclosporin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Stem Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Hydrogen Sulphide Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

6. Global Reperfusion Treatment Market, By Injury Type, 2018-2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Heart Injury
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Kidney Injury
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Intestine Injury
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

7. Global Reperfusion Treatment Market, By Distribution Channel, 2018-2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

8. Global Reperfusion Treatment Market, By Region, 2018-2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2018-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Injury Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Injury Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Injury Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Injury Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Injury Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Injury Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030, (US$ Million)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Corline Biomedical AB
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
SBI Holdings Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pharming Group NV
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Mallinckrodt Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
MIFCOR, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
CFM Pharma Holding B.V
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Balmes Transplantation SAS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Revive Therapeutics Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Faraday Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Radikal Therapeutics Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Amyndas Pharmaceuticals, com, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Angion Biomedica Corp
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Young Therapeutics, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Ischemix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Stealth Biotherapeutics Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bolder Bio Technology Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

10. Section

Research Methodology
About Us

02-2729-4219

+886-2-2729-4219

License/价格

FAQ

再灌注治疗市场：依治疗类型、按损伤类型、按分销管道、按地区：规模、份额、前景、机会分析，2023-2030

Reperfusion Treatment Market, By Treatment Type, By Injury Type, By Distribution Channel, and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

本研究的主要特点

目录

第一章研究目的与前提

第二章市场概况

第三章市场动态、法规与趋势分析

第四章全球再灌注治疗市场 - COVID-19 影响分析

第五章全球再灌注治疗市场：依治疗类型，2018-2030

第六章全球再灌注治疗市场：依损伤类型，2018-2030

第七章全球再灌注治疗市场：依通路划分，2018-2030

第八章全球再灌注治疗市场：依地区划分，2018-2030

第9章竞争格局

第10章

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Reperfusion Treatment Market- COVID-19 Impact Analysis

5. Global Reperfusion Treatment Market, By Treatment Type, 2018-2030, (US$ Million)

6. Global Reperfusion Treatment Market, By Injury Type, 2018-2030, (US$ Million)

7. Global Reperfusion Treatment Market, By Distribution Channel, 2018-2030, (US$ Million)

8. Global Reperfusion Treatment Market, By Region, 2018-2030, (US$ Million)

9. Competitive Landscape

10. Section

再灌注治疗市场：依治疗类型、按损伤类型、按分销管道、按地区：规模、份额、前景、机会分析，2023-2030

Reperfusion Treatment Market, By Treatment Type, By Injury Type, By Distribution Channel, and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

本研究的主要特点

目录

第一章 研究目的与前提

第二章 市场概况

第三章 市场动态、法规与趋势分析

第四章全球再灌注治疗市场 - COVID-19 影响分析

第五章全球再灌注治疗市场：依治疗类型，2018-2030

第六章全球再灌注治疗市场：依损伤类型，2018-2030

第七章全球再灌注治疗市场：依通路划分，2018-2030

第八章全球再灌注治疗市场：依地区划分，2018-2030

第9章 竞争格局

第10章

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Reperfusion Treatment Market- COVID-19 Impact Analysis

5. Global Reperfusion Treatment Market, By Treatment Type, 2018-2030, (US$ Million)

6. Global Reperfusion Treatment Market, By Injury Type, 2018-2030, (US$ Million)

7. Global Reperfusion Treatment Market, By Distribution Channel, 2018-2030, (US$ Million)

8. Global Reperfusion Treatment Market, By Region, 2018-2030, (US$ Million)

9. Competitive Landscape

10. Section

第一章研究目的与前提

第二章市场概况

第三章市场动态、法规与趋势分析

第9章竞争格局